Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Computer Methods in Biomechanics and Biomedical Engineering|May 12, 2025
Finite element analysis of neck sports injury based on a whole cervical spine model with musclesYing Han, Bing Zhang, Feng Zheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 29, 2019
Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate systemJing Guo, Xiaowei Xing, Na Lv, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 17, 2024
PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive MedicationsHongtao Lan, Yingbin Xi, Baoxu Kang, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 21, 2020
Continuous "Snowing" Thermotherapeutic GrapheneYangyong Sun, Zengzhen Chen, Huiping Gong, et al.
Stem Cells International|July 9, 2019
Fetal Dermal Mesenchymal Stem Cell-Derived Exosomes Accelerate Cutaneous Wound Healing by Activating Notch SignalingXiao Wang, Ya Jiao, Yi Pan, et al.
Journal of Colloid and Interface Science|May 21, 2026
X-ray-activated NaLu/GdF<sub>4</sub>:Tb<sup>3+</sup> persistent luminescence nanocarrier for synergistic radiotherapy and sustained photodynamic/chemotherapy of CancerJunqing Xiahou, Bin Liu, Kunqiang Deng, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 26, 2025
Pharmacokinetics and safety of the combination of KL130008 and methotrexate in rheumatoid arthritis patients: a multicenter, open-label phase Ib trialYue Cheng, Man Chen, Jing Yu, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
Annals of the Rheumatic Diseases|November 27, 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
Nature Genetics|October 8, 2013
A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23Yongzhe Li, Kunlin Zhang, Hua Chen, et al.
Pageof 2